Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
Xin Fang, Xin Wang, Shaoguo Yang, et al.
Frontiers in Microbiology (2016) Vol. 7
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Leaky gut: mechanisms, measurement and clinical implications in humans
Michael Camilleri
Gut (2019) Vol. 68, Iss. 8, pp. 1516-1526
Open Access | Times Cited: 780
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Nature (2019) Vol. 572, Iss. 7770, pp. 474-480
Open Access | Times Cited: 565
The progress of gut microbiome research related to brain disorders
Sibo Zhu, Yanfeng Jiang, Kelin Xu, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 357
Fecal Microbiota Transplantation in Neurological Disorders
Karuna E.W. Vendrik, Rogier E. Ooijevaar, Pieter R. C. de Jong, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 329
Gut microbiota in neurodegenerative disorders
Suparna Roy Sarkar, Sugato Banerjee
Journal of Neuroimmunology (2019) Vol. 328, pp. 98-104
Closed Access | Times Cited: 274
Role of microbiota-derived short-chain fatty acids in nervous system disorders
Rasoul Mirzaei, Behnaz Bouzari, Seyed Reza Hosseini‐Fard, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111661-111661
Open Access | Times Cited: 269
Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
Sara Gerhardt, M. Hasan Mohajeri
Nutrients (2018) Vol. 10, Iss. 6, pp. 708-708
Open Access | Times Cited: 264
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
Carolina Pellegrini, Luca Antonioli, Rocchina Colucci, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 3, pp. 345-361
Closed Access | Times Cited: 234
C9orf72 suppresses systemic and neural inflammation induced by gut bacteria
Aaron Burberry, Michael F. Wells, Francesco Limone, et al.
Nature (2020) Vol. 582, Iss. 7810, pp. 89-94
Open Access | Times Cited: 231
The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases
Anujit Sarkar, Ji Youn Yoo, Samia Valéria Ozorio Dutra, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 459-459
Open Access | Times Cited: 206
Gut inflammation and dysbiosis in human motor neuron disease
Julie Rowin, Yinglin Xia, Barbara Jung, et al.
Physiological Reports (2017) Vol. 5, Iss. 18, pp. e13443-e13443
Open Access | Times Cited: 193
The Microbiome as a Modifier of Neurodegenerative Disease Risk
Ping Fang, Sabeen A. Kazmi, Kelly G. Jameson, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 201-222
Open Access | Times Cited: 190
Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes
Cory I Wasser, Emily‐Clare Mercieca, Geraldine Kong, et al.
Brain Communications (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 153
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 124
Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases
Yueqin Li, Yao Peng, Yingbin Shen, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 29, pp. 9816-9842
Closed Access | Times Cited: 103
Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut–Liver–Brain Axes?
Huafeng Jian, Yating Liu, Xiaoming Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3900-3900
Open Access | Times Cited: 86
The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Varsha Nandwana, Nitesh Kumar Nandwana, Yogarupa Das, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3402-3402
Open Access | Times Cited: 78
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 68
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1815-1815
Open Access | Times Cited: 43
Dysbiosis in the Gut Bacterial Microbiome of Patients with Uveitis, an Inflammatory Disease of the Eye
Sama Kalyana Chakravarthy, Rajagopalaboopathi Jayasudha, Gumpili Sai Prashanthi, et al.
Indian Journal of Microbiology (2018) Vol. 58, Iss. 4, pp. 457-469
Open Access | Times Cited: 152
A randomized, double‐blind, placebo‐controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma
Chunling Jiang, Huan Wang, Chaofei Xia, et al.
Cancer (2018) Vol. 125, Iss. 7, pp. 1081-1090
Closed Access | Times Cited: 140
Implications of the Gut Microbiome in Parkinson's Disease
Mohamed Elfil, Serageldin Kamel, Mohamed Kandil, et al.
Movement Disorders (2020) Vol. 35, Iss. 6, pp. 921-933
Closed Access | Times Cited: 130
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Carolina Pellegrini, Luca Antonioli, Vincenzo Calderone, et al.
Progress in Neurobiology (2020) Vol. 191, pp. 101806-101806
Closed Access | Times Cited: 130
The fecal microbiome of ALS patients
Dávid Brenner, Andreas Hiergeist, Carolin Isabel Adis, et al.
Neurobiology of Aging (2017) Vol. 61, pp. 132-137
Closed Access | Times Cited: 122
Page 1 - Next Page

Scroll to top